Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
LaunchPrime Medicine, Inc. announces upcoming presentations of preclinical data for its Wilson's Disease program and other advances at major scientific meetings.
Prime Medicine, Inc. will present new preclinical data, including in vivo results from its Wilson's Disease program and its universal liver-directed lipid nanoparticle platform, at the European Society of Gene and Cell Therapy Congress and the American Association for the Study of Liver Diseases meeting.
Company Information
Company
Prime Medicine
Location
Cambridge, Massachusetts, United States
About
Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients. The Company is deploying its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology, to develop a new class of differentiated one-time curative genetic therapies. Designed to make only the right edit at the right position within a gene while minimizing unwanted DNA modifications, Prime Editors have the potential to repair almost all types of genetic mutations and work in many different tissues, organs and cell types. Taken together, Prime Editing’s versatile gene editing capabilities could unlock opportunities across thousands of potential indications.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Prime Medicine ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
CambridgeBiotechnologyHealth CareGeneticsTherapeutics